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ABSTRACT 
Due primarily to cell sourcing issues, many in the 
field of tissue engineering have opted to create 
scaffolds that promote in situ regeneration, using the 
body as both the bioreactor and the cell source for the 
remodeling of scaffolds, resulting in the formation of 
native tissue.  This practice raises many concerns, 
with the body’s immune response to such an implant 
often being neglected as a potential problem in 
preliminary design and biocompatibility testing.   
More importantly, what happens over time in terms 
of the immune responses as the biodegradable 
scaffold structures being utilized to promote in situ 
regeneration begin to degrade, forming structural 
fragments and degradation products?  In summary, 
immune response evaluations are critical 
considerations that must be conducted when 
evaluating bioresorbable scaffolds. In addition, it is 
essential that these evaluations analyze materials for 
their potential dose-response and time-course effects 
on the various components of innate and acquired 
immunity. 
 
EDITORIAL BODY 
Research into the immune response to biomaterials 
has been indicated as essential to a complete 
evaluation of their biocompatibility [1].  Recent work 
examining the host response to biomaterials has 
provided some insight into the inflammatory 
response to these materials.  Routine evaluations of 
biomaterials often consist of co-culturing of 
macrophages and/or L929 mouse fibroblasts with the 
material, followed by examination of various 
indicators of inflammation.  To many in the 
biomedical engineering community, this information 
is the “gold standard” by which a material is deemed 
to elicit an acceptable (or undesirable) immune 
response.  Current approaches in biomaterials 
research that investigate the effects of biomaterials on 
the immune system lack standardization, and they 
often only evaluate one small component of the 
immune response: inflammation.  Depending on the 
objective of the study, this approach may or may not 
be sufficient for evaluating immunocompetance 
following exposure to a material.  Often not 
evaluated are effects of biomaterials on acquired 
(cell-mediated, i.e. T-cell; and humoral, i.e. B-cell) 
immunity or other innate parameters, such as Natural 
Killer (NK) cell activity.  In addition, the responses 
of both innate and acquired immunity to electrospun 
biomaterials have been completely ignored. It is 
imperative that an overall assessment of 
immunomodulation be acquired for a given 
biomaterial before embarking on the more detailed, 
mechanistic approaches that pervade biomaterial 
research today.  The approach utilized by one of this 
paper’s coauthors (White, [2-9]) to evaluate 
biomaterials illustrates a comprehensive 
methodology to evaluate the multiple components of 
the immune response.  In addition, this approach 
provides a unique opportunity to advance the study of 
the immune responses to a wide variety of 
biomaterials and allows for the standardization of a 
testing hierarchy for evaluating the complete host 
immune response (both innate and adaptive 
immunity) following exposure to biomaterials. 
 
The immune response to a biomaterial is not unlike 
the reaction to any other foreign substance.  Highly 
complex and involving many different cell types, 
both innate and acquired immune responses are 
initiated when increased levels of chemokines 
(chemoattractant signals) result in the initiation of the 
inflammatory response, eliciting the infiltration of 
phagocytic cells, including polymorphonuclear cells 
(PMN) and macrophages.  In addition, biomaterial 
surface contact with the complement protein 
fragment C3b (produced continuously at low levels) 
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cascade.  By-products of this cascade (i.e. C5a, C3b, 
and iC3b) can promote macrophage activation and 
opsonization [10, 11]; macrophages can be stimulated 
to release a wide variety of signals (cytokines), 
including interleukins (IL), interferons (IFN), and 
tumor necrosis factors (TNF), which in turn mediate 
other processes, including maintaining inflammation, 
promoting T- and B-cell development, chemotaxis, 
and activation, and initiating tissue repair (collagen 
production) and angiogenesis [12].  Upon activation, 
T- and B-cells (lymphocytes) respond to foreign 
antigens, and while these responses are usually 
slower than innate responses, they are highly antigen-
specific, in contrast to innate immune responses.   
Known as adaptive immunity, these cells are capable 
of proliferation when appropriately stimulated, and 
they are highly adept at discriminating self from non-
self.  Additionally, lymphocytes are capable of 
developing a memory response, and in the event of a 
second exposure to the antigen, the immune response 
is more rapid and of a higher magnitude.  In 
particular, both the secondary antibody response 
(humoral) and the delayed-type hypersensitivity 
response (cell-mediated) quickly produce activated 
effector cells in larger numbers.  Delayed-type 
hypersensitivity (DTH) is also known as Type IV 
hypersensitivity under the Gell and Coombs 
classification and by the general population as 
contact dermatitis.  The DTH is mediated by antigen-
presenting cells and T-cells, specifically the CD-4+ 
subset of the T-cell popoulation.  Since the immune 
system is multifaceted, the question arises as to how 
exposure to a biomaterial affects the various 
components of the immune system.  There will 
undoubtedly be acute inflammation, resulting from 
the cut of a scalpel that compromises the integrity of 
the skin, a major component of innate immunity. 
Furthermore, should the biomaterial suppress or 
stimulate the immune system inappropriately, such 
modulation could be detrimental to the integrity of 
the biomaterial as well as the immunocompetance of 
the host.   
 
 
With regard to biomaterial effects on innate 
immunity, the primary focus has been on the activity 
of phagocytic cells.  The widely used synthetic 
vascular prosthetics made of Dacron
® and expanded 
polytetrafluoroethelyne (e-PTFE) have been shown to 
result in the reduction of phagocyte concentration in 
human donor blood [13].  It has also been well 
documented that e-PTFE and other biomedical 
polymers activate macrophages and increase 
production of both IL-1 and TNF-α [14-18].   
Recently, Brodbeck et al. have demonstrated that the 
surface chemistry (hydrophilicity and surface charge) 
of the biomaterial evaluated modulates expression of 
anti-inflammatory or pro-inflammatory cytokines 
[19]. 
 
Others have focused specifically on the macrophage 
and its interactions with biomaterials.  Greisler et al. 
have published extensively regarding macrophage 
interactions with synthetic bioresorbable materials, 
demonstrating that macrophage contact with these 
materials promotes activation of the macrophage, 
followed by biomaterial-specific release of growth 
factors and various cytokines [20]. In addition, they 
reported that, when cultured in media preconditioned 
by macrophage-polymer interactions, endothelial 
cells demonstrated increased 
3H-thymidine 
incorporation with increasing macrophage-material 
interaction time [21].  Macrophages have also been 
shown to promote endothelialization following 
exposure to vascular prosthetics composed of 
bioresorbable materials, where the rate of endothelial 
cell ingrowth is directly related to the rate of 
resorption of the biomaterial [22]. 
 
Perhaps the most extensively investigated biomaterial 
from an immunological standpoint is collagen.  Type 
II collagen is known for its ability to induce 
autoimmune arthritis [23], and, while types I and III 
do not initiate this response, research has indicated 
that each of these collagen types is immunogenic 
[24].  The immune responses to collagen types I, II, 
and III in a rabbit experimental model was reported 
to be T cell-mediated with minimal humoral response 
[25].  Others have indicated that T cells play a pivotal 
role in macrophage recruitment and giant cell 
formation in reaction to cross-linked dermal sheep 
collagen [26], suggesting that inflammation in 
response to collagen may be modulated by 
controlling T cell activation.  In addition, these 
researchers demonstrated that TNF-α and IFN-γ were 
not responsible for the onset of the foreign-body 
reaction to collagen in mice [27, 28].  Recently, it 
was reported that collagen fragments alone did not 
modulate innate immunity [29].  Further 
characterization of the immune response to these 
collagen fragments, using LPS-activated monocytes, 
demonstrated that IL-1 levels increased or decreased, 
depending on the peptide sequences present in the 
fragments. However, it is impossible to understand 
the significance and implications of these results 
without first having some idea as to whether they 
result in biologically relevant effects on the immune 
system.  A more complete evaluation of the effects 
on the various components of the immune system is 
needed, even for this extensively studied biomaterial. 
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polydioxanone (PDO), a bioresorbable polymer that 
is completely degraded in vivo within six months.   
PDO vascular prostheses have been shown to be less 
thrombogenic than both PGA and Dacron
® synthetic 
grafts [30], thus making them desirable to use in 
vascular tissue engineering applications.  However, 
like with other synthetic polymers, the use of PDO 
alone does not promote cell infiltration in vivo [31].  
It has been reported that PDO suture (PDS
TM-II) 
produced no sign of acute or chronic toxicological 
effects in any tissues or organs following a six-month 
in vivo implantation [32], indicating that the long-
term effects of this polymer may be negligible.   
However, studies at time points less than 6 months, 
during which the polymer is degrading, may indicate 
effects on the immune system, thus earlier time 
points must be evaluated in order to determine the 
specific effects of PDO prior to complete resorption 
of the polymer.  In contrast, PDS
TM-II suture has 
been shown to induce fibrosis after 14 days in a rat 
subcutaneous implantation model [33].  Others have 
demonstrated that soluble suture fragments of PDO 
had minimal effects on the macrophage as compared 
to silk, nylon, and polyglactin [34].  Each of the 
suture materials examined therein were indicated to 
release “immunotoxic factors,” although no specific 
factors were identified, nor were any cell types other 
than the macrophage examined.  PDO is believed to 
be less immunogenic than PGA and PLA [35], yet 
this too remains to be examined thoroughly.  Again, 
it is imperative that an overall picture of immune 
responses be obtained prior to assertions regarding a 
biomaterial’s relative effects on the immune system. 
 
Work in our lab focuses on the design and evaluation 
of tissue engineering scaffolds fabricated by 
electrospinning.  We have successfully electrospun a 
variety of synthetic polymers [35-38], natural 
polymers [39-43], and blends of the two [31, 44, 45] 
for use in a variety of tissue engineering applications.  
With the sudden increased interest of biomedical 
engineers in electrospinning, it is important that the 
effects of electrospun biomaterials upon the immune 
system be examined.  However, only limited 
published research has examined the immune 
response to sub-micron diameter fibrous 
biomaterials.  
 
Sanders, et al. have published regarding the influence 
of polymer fiber diameter on fibrous capsule 
formation and thickness [46, 47], demonstrating that 
implantation of smaller diameter fibers (1.0 μm to 5.9 
μm) resulted in thinner or no fibrotic capsule 
formation when compared to fibers with diameters 
ranging from 6.0 μm to 15.9 μm.  Missing from this 
puzzle, however, is a determination as to whether 
smaller diameter fibrous biomaterials generate 
different immune responses.  Our research has 
suggested that the biocompatibility of a material 
changes significantly between the micron and the 
nanometer fiber diameter levels [37], a suggestion 
that is not difficult to believe given the results 
reported by Sanders et al.  This further emphasizes 
the need for an examination of the immune response 
to electrospun sub-micron fibrous biomaterials.   
 
So, if study of the immune responses to biomaterials 
is truly critical, why is there so little organized focus 
on such research today?  Immune cell interaction 
with a biomaterial following implantation is 
unavoidable.  Even when bioresorbable materials are 
used (as temporary scaffolds encouraging formation 
of native tissue), cells of the immune system have 
ample opportunity for interaction with these 
materials; interaction times with permanent materials 
are likely not much longer, as the formation of a 
fibrotic capsule around permanent materials is 
probable, depending on the nature of the biomaterial.   
 
Nearly all published research on immune responses 
to biomaterials has presented too narrow a focus, a 
view too mechanistic with little characterization of 
the overall immune response first.  The result is a 
breadth of knowledge that has no contextual 
foundation.  With the appropriate biological assays as 
tools, a more complete picture of immunomodulation 
resulting from exposure to biomaterials can be 
achieved than is possible from the current 
approaches. An assortment of assays described by 
Luster et al. [48] which are typically used in 
immunotoxicological evaluations of pharmacological 
compounds can provide a more complete appraisal of 
acquired and innate immunity than is currently being 
achieved with the limited assays currently in use by 
the biomaterial community. 
 
An initial approach for examining immune responses 
following  in vitro exposure of a biomaterial could 
consist of evaluating effects on: cell-mediated 
immunity by examining T cell proliferation alone or 
in the presence of anti-CD3 antibody or the T-cell 
mitogen ConA [49], the humoral immune response 
by assessing effects on B cell proliferation (LPS-
stimulated or F(ab’)2 and IL-4 – stimulated [49]) and 
antibody production (Mishell-Dutton hemolytic AFC 
assay [50]), and innate responses by examining 
chemotaxis [51] and activity [52] of phagocytic cells, 
in addition to NK cell activity [53, 54].  In each of 
these assays, splenocyte exposure to the biomaterial 
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biomaterial for a period of time specific to each 
individual assay. 
 
Following the evaluation of immunomodulation by in 
vitro biomaterial exposure, a similar array of assays 
can be used to assess the immune responses 
following  in vivo exposure to the biomaterial [48].   
Furthermore, additional holistic assays such as the 
DTH and functional ability of the fixed macrophage 
of the mononuclear phagocyte system (MPS) can be 
evaluated.  While in vivo exposure in laboratory 
animals can model the use of biomaterials in man 
(the ultimate objective of this biomaterial research 
and development), in vitro studies have an important 
role in determining the mechanism of action and/or 
cell types involved in immune responses to 
biomaterials.   
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Using this approach, we have begun to examine 
changes in murine spleen cells following in vitro 
exposure to electrospun biomaterials.  Preliminary 
results examining the effects of several common 
biomaterials on humoral immunity have been 
obtained using the Mishell-Dutton assay, the in vitro 
counterpart to the highly sensitive plaque assay [55].  
Polymers electrospun and examined include: nylon, 
polydioxanone (PDO), poly(glycolic acid) (PGA), 
poly(lactic acid) (PLA), and a 50:50 (v:v) blend of 
PDO and polycaprolactone (PCL). Each polymer was 
dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (HFP) 
at a concentration of 100 mg/ml; 3 ml of each 
solution were electrospun at a rate of 8 ml/hr onto a 
303 stainless steel mandrel (7.7 cm x 2 cm x 0.5 cm). 
Also examined but not electrospun was e-PTFE.   
Materials were all disinfected in ethanol for a 
minimum of 10 minutes, followed by three 
successive rinses in sterile phosphate-buffered saline 
(PBS) prior to use in the culture system. 
 
As seen in Figure 1, results indicating modulation of 
antibody production following exposure to these 
synthetic polymers were obtained using a modified 
version of the in vitro hemolytic antibody-forming 
cell assay as described by Mishell and Dutton [50], in 
which splenocytes from female B6C3F1 mice were 
cultured with either 10-mm diameter circular discs of 
material or positive control (0.3 μM methotrexate, 
MTX; Sigma Aldrich).  In the Mishell-Dutton assay, 
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FIGURE 1.  In vitro Hemolytic Antibody-Forming Cell Response to Sheep Erythrocytes Following Exposure to Synthetic Polymers.  
Response to the T-dependent antigen sheep erythrocytes (sRBC) following 4 day in vitro co-culture of murine splenocytes and sRBC in the 
absence (“Media”) or presence of 10-mm diameter circular punches of material (ePTFE, nylon, PLA, PDO, PDO-PCL, PGA) or positive control 
(methotrexate, MTX; 0.3 μM).  Following culture, an aliquot of cells was added to a glass dilution tube containing agar, sRBC, and guinea pig 
complement.  The mixture was vortexed, plated on a Petri dish, and covered with a glass cover slip.  Following incubation for 3 hours at 37 °C, 
the number of antibody-forming cells (AFC) were counted using a Bellco plaque viewer.  Results were reported as AFC per culture; n = 6 for all 
groups except ePTFE, for which n = 5.  Also shown are cell viabilities following the 4-day culture period. Results were reported as % Viability, 
calculated as (Count after pronase incubation) / (Count before pronase incubation) * 100.  Statistical analysis testing included Bartlett’s test for 
homogeneity of variances followed by ANOVA and the Tukey-Kramer Multiple Comparison test; asterisks indicate a statistically significant 
difference from the control group (Media); *p < 0.05; **p < 0.01. 
 splenocytes are sensitized in vitro with the T-
dependent antigen, sheep erythrocytes.  Antibodies of 
the IgM class specific for sheep erythrocytes are 
produced by mature B cells, known as plasma cells, 
and the number of these antibody-forming cells 
(AFC) per culture are enumerated.  Several of the 
polymers tested were found to be immunosuppressive 
in this assay.  Cell counts following culture and 
removal of polymer discs were performed and 
demonstrated no differences from Media control, 
indicating cells were not lost as a result of attachment 
to the discarded polymer discs (data not shown).  Cell 
viability at the conclusion of the assay was 
determined for each culture, using the pronase 
method [56]. 
 
The implications of these results are significant, as 
they indicate that the bioresorbable electrospun 
polymers (PDO, PGA, PLA, PDO-PCL) are 
immunosuppressive in the Mishell-Dutton assay, 
while e-PTFE and electrospun nylon are not.  In 
addition, cell viability results indicate that murine 
splenocyte exposure in vitro to e-PTFE and PDO-
PCL each resulted in a significant decrease in % 
Viability (p < 0.01), while PDO also produced a 
significant decrease (p < 0.05).  This indicates that 
the decrease in cell viability contributes, in part, to 
the immunosuppressive effects of PDO and PDO-
PCL seen in this assay.   
 
While no significant differences occurred in cell 
viability between Media controls and both PGA and 
PLA, these polymers were also immunosuppressive 
in the Mishell-Dutton assay.  With no effect on 
viability, these results suggest PGA and PLA affect 
the functional ability of one or more cell types 
necessary for the formation of the in vitro antibody 
response.  The positive control, MTX is a known 
immunosuppressive drug and was used in the assay 
to demonstrate the assay was capable of detecting an 
effect if one was to occur.  
 
Current work in our laboratory is focused on 
conducting a more complete assessment of the 
immune responses to both synthetic and natural 
electrospun polymers.  We aim to achieve this 
evaluation through assays for cell proliferation, 
cytokine production, and phagocyte activity, in 
addition to antibody production capability.  In 
particular, responses of T-cells modulated by the T-
cell mitogen concanavalin A (ConA) or by anti-CD3 
antibody while in the presence of biomaterials will 
indicate whether the materials affect T-cell 
proliferation. Similarly, the responses of B-cells 
following exposure to the B-cell mitogen 
lipopolysaccharide (LPS) or following the addition of 
F(ab’)2 antibody fragments in the presence of IL-4 
will indicate any effects on B cell proliferation as a 
possible cause of the immunosuppression presented 
here.   
 
The holistic assays of humoral and cell-mediated 
immunity, i.e. the hemolytic AFC assay and Delayed-
type Hypersensitivity response, each allow for a 
sensitive evaluation of overall effects of test material 
on their respective branches of adaptive immunity. In 
addition, changes in cytokine production can also be 
measured on collected supernatants following 
splenocyte culture with test materials via the 
conventional enzyme-linked immunosorbent assay 
(ELISA).  The IgM AFC response to sRBC is one of 
the most sensitive in vivo immunotoxicological 
assays [55, 57].  Any interruption in the functions and 
interdependence of antigen processing and 
presentation by macrophages and other antigen 
presenting cells, T-cell activation, and/or B-cell 
activation can interfere in the production of 
antibodies to the sRBC antigen.  It remains to be 
determined which cell type(s) involved in this assay 
are most affected and the mechanisms by which 
biomaterials examined in this preliminary study are 
immunosuppressive. 
 
In addition, recent advances in flow cytometry, with 
the use of cytometric bead arrays, are enabling the 
simultaneous detection of multiple cytokines from a 
single sample.  With relative ease, knowledge of 
changing cytokine levels can point to cell types being 
affected by the test material. This wide-ranging 
collection of assays mentioned herein, described in 
detail by Luster, et al. [48, 55, 58] and in the 
collective works of White et al., are standards in the 
immunotoxicological evaluation of pharmaceuticals 
and other compounds and represent a starting point 
for conducting more meaningful evaluations of 
biomaterial-induced immunomodulation. 
 
To summarize, while limited information is being 
gathered in the study of the immune responses to 
various biomaterials, there is little standardization in 
the approaches undertaken by investigators. Current 
research may be too narrowly focused, without 
considering effects on the multiple components of the 
immune system.  We believe that the approach 
presented herein is efficient and effective, and that it 
will provide focus to this emerging field in the 
assessment of immune responses to all classes of 
biomaterials, including those fabricated by 
electrospinning. 
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